We have reached the end of a year like no other, and this final month of 2021 offers us once again a chance to reflect on all that has been posted in the social media sphere of diabetes. The online diabetes community (DOC) has remained ever alive while continuing to resist the COVID-19 pandemic.
Are you all crafty at Christmas? Molly at “Hugging the Cactus” Certainly does, and we enjoyed seeing her diabetes-themed adornments on display this month. While you’re at it, read Molly’s “Ode to Reese’s Cups”For another awesome, down-to-earth POV of his cactus hugging adventures.
Insulin was discovered a century ago, and in December 1921, the very first human insulin received a dose of this
In case you forgot, November was Diabetes Awareness Month. And yes, many of us in Community D are still suffering from some sort of diabetes-themed hangover from all of these activities. Yet as Tom Karlya at “Diabetes Dad” writes: “It’s good that some are rolling out diabetes advocacy during the month of November. But the truth is, we choose to fight for the rights of those living with this disease every day that we can. Insulin costs, fees and the ability to have this have everyone has been the subject of a full press all year round. So true, Tom, so true.
Unfortunately our community said goodbye to the CEO of Beyond Type 1, Thom Scher, who died suddenly in early December. Thom wasn’t living with diabetes himself, but he had been running the California nonprofit since 2019 and made a big difference to our community on many levels. Beyond that, he was just a wonderful human being and a friend to everyone who knew him. This BT1 tribute honors his heritage and his memory. Thank you for everything you have done, Thom, and you will stay in our hearts.
After a 3 year investigation, the United States House of Representatives’ Oversight and Reform Committee issued a report in December on drug pricing and Pharma’s business practices, including insulin pricing. the Beta Cell Podcast summarized these findings, noting that “In short, the report concludes what people with diabetes have known their entire lives: that Big Pharma abuses the healthcare system to increase profits at the expense of patients.” While DiabetesMine does not agree with the demonization of diabetes nonprofits for accepting pharmaceutical money, the recap and analysis is worth reading.
The Center for Medicare and Medicaid Services (CMS) made a big decision at the end of the year, extend health insurance coverage for all types of continuous glucose monitoring devices (CGMs) that have been approved by the FDA. Prior to that, Medicare coverage was only allowed for particular CGMs considered to be “non-complementary,” meaning they are deemed accurate enough to assay insulin and base decisions on diabetes without confirmatory finger testing. . It’s everything except Medtronic CGM, so Medicare has covered Dexcom, Abbott FreeStyle Libre, and Eversense implantable technology to date. With this change taking effect in early 2022, those on Medicare will also be able to get blanket for the Medtronic MiniMed CGM.
What is that ? You can’t pass up listening to a podcast with a title like this. D-Dad Scott Benner interviewed a student named Sophia Livolsi about her life with diabetes and her online presence, including her What is the bite blog and @ what.the.pick on Instagram. Make sure to listen to this Juicebox podcast episode!
Holidays and end of year celebrations are periods many of us take a step back and reflect on life, and with that in mind, we enjoyed reading this article by lawyer and author Riva Greenberg at her Diabetes Stories Blog about a poem she discovered that helps keep things in perspective.
Keep humor for the holidays, Brad Slaight at DeeHeroSquad on Instagram shares his old diabetes cartoons that were once part of our regular weekly Sunday Funnies series here at DiabetesMine. He shared this one recently, with a diabetes holiday theme.